H.I.G. Capital Moves to Build European OHS Giant with Vitaly Acquisition

Why It Matters

The acquisition illustrates how private‑equity firms are leveraging cross‑border roll‑ups to create continent‑wide platforms in sectors where regulation guarantees recurring revenue. By pairing Avanta’s mandatory OHS compliance services with Vitaly’s AI‑driven digital offerings, H.I.G. is positioning the combined business to capture both the stable, law‑driven spend and the higher‑margin, technology‑enabled services that are increasingly demanded by SMEs. The deal also showcases a growing trend of founders reinvesting alongside PE sponsors, aligning incentives and signaling confidence in long‑term value creation. For the broader PE landscape, the transaction underscores the appetite for health‑service assets that can be scaled through technology and geographic expansion. As European regulators tighten workplace safety standards, platforms that can deliver integrated, data‑rich solutions are likely to attract further capital, potentially sparking a wave of similar consolidations across the continent.

Key Takeaways

• H.I.G. Capital, via Avanta Salud, signs definitive agreement to acquire Vitaly Group
• Combined platform will serve >240,000 clients and ~4 million protected workers
• Transaction brings together 505 centres and ~5,500 employees across Spain and Portugal
• Vitaly’s co‑founders will reinvest alongside H.I.G., Avanta founder Josep Pla, and MCH Private Equity
• Deal highlights PE focus on regulated health‑service markets and AI‑enabled service differentiation

Pulse Analysis

H.I.G.’s move reflects a strategic shift from traditional buy‑and‑build models toward platform creation in high‑margin, regulated niches. The OHS sector, while historically fragmented, offers predictable cash flows due to mandatory compliance, making it an attractive anchor for private‑equity investors seeking defensive exposure. By integrating Vitaly’s AI capabilities, H.I.G. not only adds a technological moat but also creates cross‑selling opportunities for Avanta’s elective health services, potentially boosting EBITDA margins beyond the typical 10‑12% range seen in pure compliance businesses.

Historically, cross‑border consolidations in European health services have struggled with integration risk, especially around data privacy and differing national regulations. H.I.G.’s decision to keep the combined entity under the Avanta brand, coupled with the founders’ continued equity stakes, mitigates cultural friction and ensures continuity of client relationships. If the integration proceeds smoothly, the platform could serve as a template for similar roll‑ups in France, Italy, and the Nordics, where OHS compliance markets are similarly fragmented.

Looking ahead, the success of this platform will hinge on how quickly the AI‑driven tools can be rolled out across the enlarged client base and whether the combined entity can leverage its scale to negotiate better pricing with suppliers and insurers. Should H.I.G. achieve these operational levers, the platform could command a premium valuation in a future exit, potentially setting a new benchmark for PE multiples in the European health‑services space.